There were 15 main board IPOs in December 2024 of Suraksha Diagnostics Limited, as One Mobikwik Systems Limited, Sai Life Sciences Limited, Vishal Mega Mart Limited, Inventurus Knowledge Solutions LIMITED, International Gemmolgical Institue India Limited, Transrail Lighting Limited, Mamata Mahinery Limited, Concord Enviro Systems Limited, Sanathan Textiles Limited, DAM Capital Advisors Limited, Senores Pharamceuticals Limited, Xarraro India Limited, Ventive Hospitality Limited and UNimech Aerospace & Manufacturing Limited against 08 main board IPOs in November 2024. There were 07 SME IPOs in December 2024 as against 01 SME IPOs in November 2024.
Mamata Machinery Limited:
|
About the Company |
Incorporated in April 1979, Mamata Machinery Limited manufactures and exports machines for making plastic bags, pouches, packaging, and extrusion equipment. The company provides manufacturing solutions for the packaging and caters to FMCG, Food, & Beverage industries in 75+ countries. In March 2024, the company reported a revenue of Rs. 237 crore and a profit after tax (PAT) of 36 crore. |
|
Funds Utilization |
The company will not receive any proceeds from the public issue, and the entire fund will go to the selling shareholders, after deducting IPO-related expenses. |
|
Selling Shareholders |
The company’s promoters Mahendra Patel, Nayana Patel, Bhagvati Patel, Mamata Group Corporate Services LLP, and Mamata Management Services LLP sold their stakes in the public offering. |
|
Objective |
To gain the listing benefits of equity shares on the stock exchanges, boost its visibility and brand image, provide liquidity to its shareholders, and establish a public market for the shares. |
|
IPO Performance |
The Rs. 179 Crore IPO was entirely an offer for sale. The issue was oversubscribed over 195 times, with Non- Institutional investors subscribed the most at 274 times to the issue. Shares of Mamata Machinery Limited made a bumper debut on the bourses on December 27, and got listed at Rs 600 on both BSE and NSE, i.e. a premium of 147% percent over the issue price of Rs 243. |
Funds Mobilization by Corporates (Rs. In Crore)
|
Particulars |
Oct-24 |
Nov-24 |
|
I. Equity Issues |
54,616 |
49,507 |
|
a. IPOs (i+ii) |
34,981 |
35,849 |
|
i. Main Board |
33,757 |
35,729 |
|
ii. SME Platform |
1,224 |
120 |
|
b. FPOs |
0 |
0 |
|
c. Equity Rights Issues |
670 |
417 |
|
d. QIPs/IPPs |
15,589 |
11,190 |
|
e. Preferential Allotments |
3,376 |
2,051 |
|
II. Debt Issues |
76,752 |
67,758 |
|
a. Debt Public Issues |
670 |
218 |
|
b. Private Placement of Debt |
76,082 |
67,540 |
|
III. REITs/ InvITs |
694 |
0 |
|
a. REITs |
0 |
0 |
|
b. InvITs |
694 |
0 |
|
Total Funds Mobilized (I+II+III) |
1,32,062 |
1,17,265 |
Acknowledgements:
RBI Bulletin (www.bulletin.rbi.org.in), SEBI (www.sebi.gov.in), NSE (www.nseindia.com), BSE (www.bseindia.com)
Disclaimer:
This material has been prepared by the personnel in Vora Corporate Finance which is Investment Banking arm of Vora Management Consultancy Private Limited and looks after Mergers & Acquisitions (M&A), Private Equity (PE), Fund Raising, Debt syndication and Valuations and is based out of Ahmedabad, Gujarat, India. Any views or opinions expressed herein are solely that of individual authors and may differ from view of Vora Management Consultancy Private Limited. This material is proprietary to Vora Management Consultancy Private Limited and is for your personal use only. Any distribution, copy, reprints or forward to others is strictly prohibited.
This material captures the information based on information available in the public domain, public announcements and sources believed to be reliable. Analysis contained herein is based on publicly available information and appropriate assumptions. This material is intended merely to highlight market developments and is not intended to be comprehensive and does not constitute strategic, investment, legal or tax advice. In no event Vora Management Consultancy Private Limited be liable for any use by any party or for any decision made or action taken by any party in reliance upon, or for any inaccuracies or errors in, or omissions from, the information contained herein and such information may not be relied upon by you for evaluating any transaction.